[Significance of intensive follow-up in patients with advanced prostatic carcinoma undergoing hormonal treatment].
D003692:Delayed-Action Preparations; D005500:Follow-Up Studies; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives / Q000627:therapeutic use; D017273:Goserelin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000473:pathology / Q000628:therapy*; D012189:Retrospective Studies
D003692:Delayed-Action Preparations; D017273:Goserelin; D007987:Gonadotropin-Releasing Hormone
Significato del follow-up intensivo nei pazienti portatori di carcinoma prostatico avanzato in trattamento ormonale.